齐鲁细胞治疗

Qilu Cell Therapy Technology Co., Ltd., a subsidiary of Qilu Pharmaceutical Group, is a biotechnology company focused on the development and commercialization of advanced cell therapies. The company specializes in mesenchymal stem cells (MSCs) and immune cell technologies, including NK cells and CAR-T cells, targeting indications in oncology, orthopedics, and regenerative medicine. Qilu Cell operates a comprehensive GMP-compliant facility that integrates cell storage, research and development, and large-scale manufacturing. Their pipeline features several clinical-stage programs, most notably MSC-based treatments for knee osteoarthritis and liver cirrhosis. Additionally, the company provides CDMO services to support the broader cell and gene therapy industry. By leveraging the resources of the Qilu Pharmaceutical Group, the company has established one of the largest cell resource banks in China.